Estimated schedule for the first execution of the "Viscofan Retribución Flexible" optional dividend system
In connection
with the optional dividend system "Viscofan Retribución Flexible"
for the 2024 fiscal year approved today by the Company's General Shareholders'
Meeting, the Board of Directors of the Company approved at its meeting held
today, after the aforementioned General Shareholders' Meeting, the estimated calendar
for the first edition of the aforementioned system.
In accordance
with the resolutions adopted by the General Shareholders' Meeting, the shareholders
of the Company may choose between the following options: (i) receive their
remuneration through the delivery of new fully paid-up shares, (ii) transfer
all or part of their free allocation rights (derechos de asignación gratuita)
in the market, or (iii) receive their remuneration in cash (the "Supplementary
Dividend" and the "Flexible Remuneration Options").
The shareholders of the Company may combine any of the aforementioned
alternatives with respect to the different groups of shares held by each
shareholder.
The estimated calendar
for the first execution of the optional dividend system "Viscofan Retribución
Flexible" corresponding to the fiscal year 2024 will be as follows:
14 May 2024
|
Publication
of the Information Memorandum.
|
22 May 2024
|
Notice
regarding the number of free allocation rights (derechos de asignación
gratuita) required to receive one share and the gross amount of
Supplementary Dividend per share. For the determination of these items, the
formula approved by the Company's General Shareholders' Meeting will be
applied, which will take into consideration the arithmetic average of the
weighted average trading prices of the Company's shares on the Madrid,
Barcelona and Bilbao Stock Exchanges in the five trading sessions
corresponding to May 15, 16, 17, 20 and 21, 2024.
|
27 May 2024
|
Publication
of the announcement of the execution of the capital increase in the Official
Gazette of the Commercial Registry.
Last
day on which the Company's shares will be traded with the right to
participate in the optional dividend system "Viscofan Retribución Flexible",
that is, with the right to opt for any of the Flexible Remuneration Options
offered by this system (including the Supplementary Dividend) (last trading date).
|
28 May 2024
|
Reference
date (ex date) from which -including
such date- the Company's shares will be traded without the right to
participate in the optional dividend system "Viscofan Retribución
Flexible".
Commencement
of the common election period and trading period of the free allocation
rights (derechos de asignación gratuita).
|
11 June 2024
|
End
of the common election period and trading period for free allocation rights (derechos
de asignación gratuita).
|
24 June 2024
|
Payment
of the Supplementary Dividend to those who have elected to receive cash
through this Flexible Remuneration Option.
Registration
of the new shares to be issued as a result of the capital increase in
IBERCLEAR's book-entry records.
|
26 June 2024
|
Expected
date for the commencement of trading of the new shares to be issued as a
result of the capital increase.
|
Notice is also given that the Board of Directors has
today adopted the resolutions necessary for the execution, in accordance with
the communicated calendar, of the payment of the supplementary dividend and the
first share capital increase and, for such purposes and in accordance with the
provisions of Article 1.5(g) of Regulation (EU) 2017/1129 of the European Parliament
and of the Council of 14 June 2017 on the prospectus to be published when
securities are offered to the public or admitted to trading on a regulated
market and repealing Directive 2003/71/EC, has approved the corresponding
information memorandum relating to the first execution of the optional dividend
system "Viscofan Retribución Flexible" corresponding to the fiscal
year 2024 (the "Information Memorandum"). The Information Memorandum
will be communicated as "Other Relevant Information" on 14 May 2024 prior
to the launching of the execution process of the referred system.
Finally, the Board of Directors has also adopted the
necessary resolution to carry out, pursuant to the resolution adopted today by
the General Shareholders' Meeting under item eight on the agenda, a share capital
decrease for a nominal amount equal to the nominal amount for which the first
share capital increase in the context of the Flexible Remuneration Options is
effectively executed.